Mednet Logo
HomeNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How do you balance short-term efficacy against increased low-grade toxicity and quality-of-life considerations for higher single-fraction regimens in recurrent glioma patients?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic Rochester

When considering radiation options for recurrent glioma, in my mind, one size does not fit all. I consider several aspects of the specific patient’s clinical situation: Patient’s prior treatments: time interval, volume, location, and anatomic site, response to prior treatment, response duration from...

How do you approach evaluating the hemorrhage risk of restarting anticoagulation in a patient with ischemic stroke and infective endocarditis without access to DSA?

1
2 Answers

Mednet Member
Mednet Member
Neurology · NYU

This is a really excellent question. First of all, if the patient has infective endocarditis, they really should undergo appropriate antibiotic treatment prior to initiating anticoagulation. I have seen several patients have significant (and in some cases fatal) hemorrhages because anticoagulation w...

When do you find benefit in sequencing different dopamine receptor blockers for emergency treatment of migraine?

1
2 Answers

Mednet Member
Mednet Member
Neurology · Greater Boston Headache Center at Boston Advanced Medicine

I know that these medications given intravenously have been found effective abortively in randomized, double-blinded, placebo-controlled trials. Prior to the advent of the triptans in the early nineties, I often treated migraine headaches abortively with metoclopramide 10 mg orally, in 15 minutes, f...

How do you decide on the speed and target of blood pressure reduction for spontaneous intracranial hemorrhage?

3
4 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

I think the target and speed of blood pressure reduction in ICH depend on several variables, including initial SBP, clinical stability, hematoma size, and renal function. For patients presenting with SBP >220, I typically aim to lower the pressure to around SBP 160 over the first 12 hours, then grad...

How do you treat nocturnal leg cramps?

5
8 Answers

Mednet Member
Mednet Member
Neurology · VUMC Neurology

Nocturnal leg cramps are similar to daytime leg cramps, but stretching may be less convenient to use as a remedy, as sleep can be further disrupted. Treating and preventing leg cramps typically utilizes some combination of hydration and electrolytes but sometimes, medications can help. Consider the ...

How would you balance the risk of intracranial hemorrhage with thrombosis of mechanical valves in patients with infective endocarditis?

1 Answers

Mednet Member
Mednet Member
Cardiology · Ohio State University Cardiovascular Medicine

I'm not sure that there is a good answer to this question. If you look at it segmentally, clearly, patients with mechanical valves require anticoagulation, especially in the mitral position. In patients with endocarditis and native valves, whether or not to anticoagulate the patient after or before ...

Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?

4 Answers

Mednet Member
Mednet Member
Neurology · USF Health

Good question! :-) Lateralized rhythmic delta (LRDA), especially temporal (TRDA) certainly does, basically to the same degree as interictal epileptiform discharges (IEDs). Focal polymorphic slowing is of course not technically "epileptiform" but it does indicate some focal dysfunction, so I would sa...

How do you decide between FcRn inhibitors and complement inhibitors for treatment-refractory AChR-positive myasthenia gravis?

1
4 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

UPDATE (02/2025):In the last two years, there have been few real-world comparative efficacy studies published to address this question. I have attached a selection of them below. Overall the conclusion is that equipoise remains- there is no clear evidence of the superiority of complement inhibitors ...

How do the results of CREST-2 influence your recommendations on screening for asymptomatic carotid stenosis?

2 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

Agree with the prior comment. One important nuance is what “medical management” actually meant in CREST-2. This was centralized, protocol-driven care with structured lifestyle counseling and medication escalation, including access to PCSK9 inhibitors with costs covered. Even in that highly organized...

When can EMG be deferred in cases of distal sensory polyneuropathy?

1 Answers

Mednet Member
Mednet Member
Neurology · Cedars-Sinai Medical Center

Sensory conduction studies provide information as to whether there is a large fiber disorder of the dorsal root ganglion or the nerve fibers distal to the DRG. The simple answer to the question is that you can defer this study when you don't want or need that information. If the symptoms are very di...